Automated NGS library prep market seen reaching $1.35 billion by 2030
The automated next-generation sequencing library preparation market is projected to grow from $0.72 billion in 2025 to $0.82 billion in 2026, according to The Business Research Company. The report points to gene therapy, diagnostics and automation in lab workflows as key drivers, with North America leading now and Asia-Pacific set for the fastest growth.
Why it matters: - Automated NGS library preparation is becoming a core workflow in genomics and clinical testing. - Faster, more standardized preparation can improve sequencing consistency and reduce human error. - The market’s growth signals broader demand for scalable sequencing infrastructure in research and healthcare.
What happened: - The Business Research Company published its Automated Next-Generation Sequencing Global Market Report 2026 – Market Size, Trends, And Forecast 2026-2035. - The report estimates the market will rise from $0.72 billion in 2025 to $0.82 billion in 2026. - The report forecasts the market will reach $1.35 billion by 2030. - The 2026-2030 forecast implies a 13.3% CAGR. - Historical growth has been driven by genomic research, wider clinical adoption of NGS, precision medicine programs, demand for scalable sequencing workflows and advances in sequencing chemistry.
The details: - Automated NGS library preparation uses robotic systems and software to handle DNA or RNA prep steps for sequencing. - Core steps include fragmentation, end-repair, adapter ligation and amplification. - Automation is designed to improve consistency, scalability and workflow reliability in high-throughput sequencing. - The report says future growth will be supported by the growing role of NGS in diagnostics, more investment in automated lab infrastructure, expansion of population genomics programs, demand for faster turnaround and rising use of single-cell sequencing. - Expected trends include wider adoption of fully automated library preparation platforms, greater demand for high-throughput sequencing, more robotics in sample processing, standardized NGS pipelines and efforts to reduce errors while improving workflow consistency. - The report identifies gene therapy as a major growth driver because automated library prep supports analysis and validation of genetic modifications. - In April 2024, the American Society of Gene and Cell Therapy reported a 10% increase in phase III gene therapy clinical trials in the fourth quarter of 2023, the first quarterly rise since the third quarter of 2022. - The report also says its 2026 edition includes market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technology analysis and updated graphics and tables.
Between the lines: - The market outlook suggests sequencing automation is shifting from a lab efficiency upgrade to an enabling layer for clinical and translational research. - Gene therapy activity appears to be an important demand signal because it depends on precise genetic analysis and validation. - The emphasis on standardized pipelines and reproducibility points to pressure on labs to scale without sacrificing quality.
What's next: - North America is expected to remain a major market because of its strong infrastructure and adoption base. - Asia-Pacific is projected to be the fastest-growing region over the forecast period, driven by investment and research activity. - The report also covers South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa. - Researchers and buyers can access a free sample of the report and the full market report.
Disclaimer: This article was produced by AGP Wire with the assistance of artificial intelligence based on original source content and has been refined to improve clarity, structure, and readability. This content is provided on an “as is” basis. While care has been taken in its preparation, it may contain inaccuracies or omissions, and readers should consult the original source and independently verify key information where appropriate. This content is for informational purposes only and does not constitute legal, financial, investment, or other professional advice.
Sign up for:
Africa News Guide
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.